Company established
2016.08
Completed construction of GMP level 10000 clean room.
2019.05
Obtained A-round Financing from Lianxin capital, Puhua capital and Efung Capital
2020.08
Approval of application for innovative medical devices by the NMPA.
2021.06
Approval of Corheart 6 Clinical trial
2022.01
2019.04
Recieved the First round investment from Hetang Venture Capital.
2019.12
Recognized as a national high-tech enterprise.
2021.05
Obtained B-round Financing from Hillhouse capital and CICC capital
Completed type inspection of the Coreart 6.
2021.10
FIM of the Corheart 6.
2022.07
